Tevogen entered a non-binding, non-exclusive letter of intent to evaluate acquiring HRK Healthcare, targeting a close by year-end.
We only link to sources you can read without a subscription. How we check.
Viatris agreed to buy Pacira BioSciences in a roughly $1.7B buyout. The deal brings in post-surgical pain drug Exparel and knee osteoarthritis therapy Zilretta, which together booked nearly $700M in 2025. Leerink expects the deal to be immediately accretive to revenue.
China's Midea Group has completed its acquisition of a controlling stake in Esaote, a Genoa-based medical imaging company known for ultrasound and dedicated MRI. Esaote will join Midea Healthcare, operate independently and stay under CEO Franco Fontana. Terms were not disclosed.
CardioOne joined forces with CardioSphere and welcomed Midwest Cardiovascular Institute to its independent cardiology network.
Pharma services platform Petauri acquired HEOR and market access consultancy Franklin Pharmaceutical Consulting.